Alicia Semaka
Affiliations: | 2006-2012 | Medical Genetics | University of British Columbia, Vancouver, Vancouver, BC, Canada |
Google:
"Alicia Semaka"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wright GEB, Collins JA, Kay C, et al. (2019) Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease. American Journal of Human Genetics |
| Austin J, Semaka A, Hyunh S. (2019) GENETIC COUNSELING AS A WAY TO ENGAGE PEOPLE IN BEHAVIOUR CHANGE TO REDUCE RISK FOR COMMON COMPLEX DISEASE: RATIONALE FOR ITS POTENTIAL EFFECTIVENESS WHERE GENETIC INFORMATION HAS FAILED European Neuropsychopharmacology. 29: S1029 |
| Kay C, Collins JA, Wright GEB, et al. (2018) The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics |
| Andrighetti H, Semaka A, Stewart SE, et al. (2015) Obsessive-Compulsive Disorder: The Process of Parental Adaptation and Implications for Genetic Counseling. Journal of Genetic Counseling |
| Semaka A, Kay C, Belfroid RD, et al. (2015) A new mutation for Huntington disease following maternal transmission of an intermediate allele. European Journal of Medical Genetics. 58: 28-30 |
| Austin J, Semaka A, Hadjipavlou G. (2014) Conceptualizing genetic counseling as psychotherapy in the era of genomic medicine. Journal of Genetic Counseling. 23: 903-9 |
| Semaka A, Hayden MR. (2014) Evidence-based genetic counselling implications for Huntington disease intermediate allele predictive test results Clinical Genetics. 85: 303-311 |
| Semaka A, Kay C, Doty CN, et al. (2013) High frequency of intermediate alleles on Huntington disease-associated haplotypes in British Columbia's general population. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 162: 864-71 |
| Houge G, Bruland O, Bjørnevoll I, et al. (2013) De novo Huntington disease caused by 26-44 CAG repeat expansion on a low-risk haplotype. Neurology. 81: 1099-100 |
| Semaka A, Kay C, Doty C, et al. (2013) CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease. Journal of Medical Genetics. 50: 696-703 |